Methyl 2-[3-(benzyloxy)phenyl]acetate

CAS: 62969-42-0

Ref. 3D-MCA96942

Produktinformation

• Name: Methyl 2-[3-(benzyloxy)phenyl]acetate
• Synonyme: Methyl 3-(phenylmethoxy)benzeneacetate, 3-Benzyloxyphenylacetic acid methyl ester, Methyl [3-(benzyloxy)phenyl]acetate, Benzeneacetic acid, 3-(phenylmethoxy)-, methyl ester

Beschreibung

Methyl 2-[3-(benzyloxy)phenyl]acetate (MBPCA) is a patent-pending lead compound with potential pharmacological applications as an inhibitor of acetyl-coa carboxylase. MBPCA has been shown to reduce plasma triglyceride levels in subchronic studies and is being developed as a potential treatment for hypertriglyceridemia. MBPCA has been shown to be effective against high fat diet-induced obesity, increasing the level of fat oxidation and reducing body weight gain. The pharmacokinetic properties of MBPCA are currently being optimized, including parameters such as bioavailability, volume of distribution, and clearance.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 256.3 g/mol
• Formel: C₁₆H₁₆O₃
• Reinheit: Min. 95%